Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Guðmundur K Jónmundsson"'
Autor:
Johan Malmros, Kirsi Jahnukainen, Henrik Hasle, Steen Østergaard Olsen, Guðmundur K Jónmundsson, Anne-Sofie Skou, Marianne Jarfelt, Lars Holme Nielsen, Heidi Glosli, Karsten Nysom
Publikováno v:
Skou, A-S, Olsen, S Ø, Nielsen, L H, Glosli, H, Jahnukainen, K, Jarfelt, M, Jónmundsson, G K, Malmros, J, Nysom, K & Hasle, H 2019, ' Hearing Status in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study ', Journal of Pediatric Hematology/Oncology, vol. 41, no. 1, pp. e12-e17 . https://doi.org/10.1097/MPH.0000000000001302
As more children survive acute myeloid leukemia (AML) it is increasingly important to assess possible late effects of the intensive treatment. Hearing loss has only sporadically been reported in survivors of childhood AML. We assessed hearing status
Autor:
Johan Malmros, Marianne Jarfelt, Kirsi Jahnukainen, Heidi Glosli, Niels Holmark Andersen, Karsten Nysom, Guðmundur K Jónmundsson, Henrik Hasle
Publikováno v:
Jarfelt, M, Andersen, N H, Glosli, H, Jahnukainen, K, Jónmundsson, G K, Malmros, J, Nysom, K, Hasle, H & Nordic Society of Pediatric Hematology and Oncology (NOPHO) 2015, ' Cardiac function in survivors of childhood acute myeloid leukemia treated with chemotherapy only : a NOPHO-AML study ', European Journal of Haematology . https://doi.org/10.1111/ejh.12683
OBJECTIVES: We report cardiac function of patients treated for Childhood acute myeloid leukemia with chemotherapy only according to three consecutive Nordic protocols.METHODS: Ninety-eight of 138 eligible patients accepted examination with standardiz
Autor:
Anne-Sofie Skou, Kirsi Jahnukainen, Heidi Glosli, Guðmundur K Jónmundsson, Marianne Jarfelt, Henrik Hasle, Karsten Nysom, Johan Malmros-Svennilson
Publikováno v:
Pediatric Blood & Cancer. 61:1638-1643
BACKGROUND: We investigated the spectrum, frequency, and risk factors for renal, gastrointestinal, and hepatic late adverse effects in survivors of childhood acute myeloid leukemia (AML) without re ...
Autor:
Kirsi Jahnukainen, Anne-Sofie Skou, Johan Malmros, Karsten Nysom, Marianne Jarfelt, Henrik Hasle, Heidi Glosli, Guðmundur K Jónmundsson, Anders Juul, Lene Molgaard-Hansen
Publikováno v:
Pediatric Blood & Cancer. 60:1988-1995
Background More than 60% of children with acute myeloid leukemia (AML) become long-term survivors. Most are cured using chemotherapy without hematopoietic stem cell transplantation (HSCT). We report on pubertal development and compare self-reported p
Autor:
Karl G. Kristinsson, Guðmundur K. Jónmundsson, Þórólfur Guðnason, Helga Erlendsdóttir, Ásgeir Þór Másson, Mar Kristjansson, Ásgeir Haraldsson
Publikováno v:
Læknablaðið. 2011:91-96
OBJECTIVE The main objective was to determine the incidence and causative pathogens of osteomyelitis and septic arthritis in Icelandic children, as well as presenting symptoms and diagnosis. METHODS A nationwide retrospective review was done of all c
Autor:
Guðmundur K Jónmundsson, Merja Möttönen, Jonas Abrahamsson, Henrik Hasle, Lene Molgaard-Hansen, Heidi Glosli
Publikováno v:
British Journal of Haematology. 152:623-630
Summary The frequency and causes of treatment-related deaths (TRD) in second complete remission (CR2) in acute myeloid leukaemia (AML) were investigated in a historical, prospective cohort study of 429 children included in the Nordic Society of Paedi
Autor:
Kirsi Jahnukainen, Guðmundur K Jónmundsson, Marianne Jarfelt, Henrik Hasle, Heidi Glosli, Lene Molgaard-Hansen, Johan Malmros-Svennilson, Karsten Nysom
Publikováno v:
Pediatric Blood & Cancer. 57:1222-1229
Acute myeloid leukemia (AML) represents 20% of the acuteleukemiacasesinchildrenandadolescents.IntheNordiccountries,AML is diagnosed in approximately 30 children annually in a totalchildpopulationof4.5millionbelowtheageof15years.Thepasttwodecadeshaves
Autor:
Olafur G. Jonsson, Jon G. Jonasson, Jón R. Kristinsson, Trausti Oskarsson, Ásgeir Haraldsson, Guðmundur K. Jónmundsson
Publikováno v:
Læknablaðið. 2010:675-680
OBJECTIVE Of children diagnosed with cancer, approximately one fourth die of the disease or disease related complications. The aim of this study was to investigate survival and causes of death in children with cancer in Iceland. METHODS This study is
Autor:
Jonas Abrahamsson, Merja Möttönen, Henrik Hasle, Guðmundur K Jónmundsson, Heidi Glosli, Lene Molgaard-Hansen
Publikováno v:
British Journal of Haematology. 151:447-459
Despite major improvements in the cure rate of childhood acute myeloid leukaemia (AML), 5-15% of patients still die from treatment-related complications. In a historical prospective cohort study, we analysed the frequency, clinical features and risk
Autor:
Trausti Oskarsson, Kristinsson, Jon G. Jonasson, Olafur G. Jonsson, Ásgeir Haraldsson, Guðmundur K. Jónmundsson
Publikováno v:
Læknablaðið. 96:21-26
BACKGROUND Childhood cancer is the second most common cause of death in children. The aim of this study was to gather epidemiological information on childhood cancer in Iceland. METHODS The study was population based and included all children younger